Abstract:OBJECTIVE: This investigation has focused to characterize the elastic liposome containing 5-fluorouracil (5-FU) and to enhance drug permeation across stratum corneum (SC) of the skin (rat) using various surfactants and in vivo dermal toxicity evaluation.METHODOLOGY: 5-FU-loaded elastic liposomes were developed, prepared and characterized for their entrapment efficiency, vesicle size, number of vesicles, morphological characteristics, surface charge and turbidity. In vitro drug release profile, in vitro skin permeation potential and in vitro hemolytic ability of the formulation have been evaluated to compare with drug solution for 24 h. In vitro skin permeation potential was also compared with marketed cream. Furthermore, in vivo skin irritation potential, drug penetration into the skin using confocal laser scanning microscopy (CLSM) and in vivo toxicity studies were performed.RESULTS AND CONCLUSIONS: The optimized elastic liposomes demonstrated maximum drug entrapment efficiency, optimum vesicular size and considerable elasticity. In vitro skin permeation studies showed the highest drug permeation flux like 77.07 ± 6.34, 89.74 ± 8.5 and 70.90 ± 9.6 µg/cm(2)/h for EL3-S60, EL3-S80 and EL3-T80, respectively, as compared to drug solution (8.958 ± 6.9 µg/cm(2)/h) and liposome (36.80 ± 6.4 µg/cm(2)/h). Drug deposition of optimized elastic liposome EL3-S80 was about three fold higher than drug solution. Skin irritation and CLSM studies suggested that optimized gel was free from skin irritation and capable to deliver 5-FU into the epidermal area for enhanced topical delivery than drug solution. The in vitro study showed minimum hemolysis in the optimized formulation. Finally, in vivo toxicity studies followed with hisptopathological assessment showed that elastic liposome was able to extract SC to improve drug permeation without changing general anatomy of the skin.

Transdermal diffusion of fluorouracil in niosomal gels in vitro

Penetration profile and human cadaver skin distribution of finasteride from vesicular nanocarriers.

[Microemulsion-Based Gel of Fluorouracil for Transdermal Delivery].

Water in Oil Microemulsions for Transdermal Delivery of Fluorouracil

Studies on N3-O-toluyl-Flulorouracil(Tfu)Liposomes

Synthesis of Hydrogels Loaded 5-Fluorouracil and in Vitro Evaluation for Transdermal Delivery

Study on the Preparation and Properties of Fluorouracil Stealth Niosomes in Vitro

In vitro and in vivo studies of lipid-based nanocarriers for oral N<sub>3</sub>-o-toluyl-fluorouracil delivery

Enhanced oral bioavailability and absorption mechanism study of N3-O-toluyl-fluorouracil-loaded liposomes

Investigation Of Nanostructured Lipid Carriers For Transdermal Delivery Of Flurbiprofen

Water in Oil Microemulsions Containing NaCl for Transdermal Delivery of Fluorouracil

Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation

The in vitro anti-tumor efficacy and the pharmacokinetics of N 3-O-toluyl-fluorouracil loaded nanosuspension (TFu-LNS)

Preclinical Studies of N3-O-toluyl-fluorouracil-loaded Lipid-Based Nanosuspensions in H22-bearing Mice

Study on the permeability of naftifine hydrochloride in vitro

The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil.

In vitro/vivo transdermal permeation of tacrolimus niosomes gel

Preparation and Characterization of 5-Fluorouracil Ph-Sensitive Niosome and Its Tumor-Targeted Evaluation: in Vitro and in Vivo.

Studies on in vitro Transdermal Permeability of Nifedipine Nanoemulsion Containing Different Permeation Enhancers

Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)

Release mechanism studies on TFu nanoparticles-in-microparticles system.